{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:36:29Z","timestamp":1792143389438,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ajog.2026.07.026","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:44:48Z","timestamp":1785426288000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Abnormal serum soluble fms-like tyrosine kinase 1 and placental growth factor as markers of occult placental dysfunction and fetal risk in pregestational diabetes: a prospective masked cohort study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-7934","authenticated-orcid":false,"given":"Ruth C.E.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Williman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2026.07.026_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/AOG.0000000000005682","article-title":"Pre-existing diabetes and stillbirth or perinatal mortality: a systematic review and meta-analysis","volume":"144","author":"Blankstein","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajog.2024.11.026","article-title":"Pregnancy outcomes in type 2 diabetes: a systematic review and meta-analysis","volume":"232","author":"Clement","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib3","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2337\/dc25-0833","article-title":"Maternal diabetes, fetal growth, and stillbirth risk: A population-wide retrospective cohort study from Victoria, Australia","volume":"48","author":"Gordon","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.07.026_bib4","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.3390\/jcm14134789","article-title":"Pregestational diabetes mellitus and adverse perinatal outcomes: A systematic review and meta-analysis","volume":"14","author":"Gazis","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajog.2026.07.026_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ajog.2026.07.026_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1471-0528.18339","article-title":"Glycaemic control in women with type 1 diabetes and preeclampsia risk: a nationwide cohort study","volume":"133","author":"Holowko","year":"2026","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.07.026_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2026.07.026_bib8","first-page":"1081","article-title":"Diabetes and pregnancy: national trends over a 15 year period","volume":"61","author":"Mackin","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajog.2026.07.026_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajog.2024.05.042","article-title":"Stillbirth: we can do better","volume":"231","author":"Silver","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/dme.12502","article-title":"Women with pre-gestational diabetes have a higher risk of stillbirth at all gestations after 32 weeks","volume":"31","author":"Holman","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/j.ajog.2026.07.026_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/AOG.0000000000005102","article-title":"Risk of stillbirth in pregnancies complicated by diabetes, stratified by fetal growth","volume":"141","author":"McElwee","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3109\/10641955.2016.1172085","article-title":"Time-specific placental growth factor (PlGF) across pregnancy and infant birth weight in women with preexisting diabetes","volume":"35","author":"James-Todd","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2026.07.026_bib13","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00125-021-05438-y","article-title":"Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?","volume":"64","author":"Bacon","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajog.2026.07.026_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00125-022-05820-4","article-title":"Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?","volume":"66","author":"Desoye","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajog.2026.07.026_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dc23-2304","article-title":"Hemoglobin A1c trajectories during pregnancy and adverse outcomes in women with type 2 diabetes: A Danish national population-based cohort study","volume":"47","author":"Koefoed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.07.026_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41574-022-00717-z","article-title":"Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity","volume":"18","author":"Desoye","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajog.2026.07.026_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2337\/dc17-0391","article-title":"The association of falling insulin requirements with maternal biomarkers and placental dysfunction: a prospective study of women with preexisting diabetes in pregnancy","volume":"40","author":"Padmanabhan","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.07.026_bib18","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.3390\/jcm14217737","article-title":"Falling third trimester insulin requirements and adverse pregnancy outcomes in individuals with pre-existing diabetes: a retrospective cohort study","volume":"14","author":"Vainder","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajog.2026.07.026_bib19","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2026.07.026_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/GRF.0000000000000972","article-title":"The Role of angiogenic Factors in Fetal growth restriction","volume":"68","author":"Bartels","year":"2025","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/aogs.13978","article-title":"Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age","volume":"100","author":"Garcia-Manau","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2026.07.026_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.44454","article-title":"Midpregnancy placental growth factor screening and early preterm birth","volume":"7","author":"Gladstone","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2026.07.026_bib24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41591-024-03421-9","article-title":"Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial","volume":"31","author":"Garcia-Manau","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2026.07.026_bib25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/1471-0528.70106","article-title":"Placental growth factor led management of the small for gestational age fetus: randomised controlled feasibility study","volume":"133","author":"Bullough","year":"2026","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2026.07.026_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13904","article-title":"Placental senescence and the two-stage model of preeclampsia","volume":"92","author":"Sugulle","year":"2024","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2026.07.026_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.08.025","article-title":"Soluble fms-like tyrosine kinase-1\/placental growth factor ratio at 36 weeks\u2019 gestation: association with spontaneous onset of labor and intrapartum fetal compromise in low-risk pregnancies","volume":"232","author":"Farina","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ajog.2026.07.026_bib29","first-page":"e237","article-title":"Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2026.07.026_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib33","author":"Gardosi"},{"key":"10.1016\/j.ajog.2026.07.026_bib34","doi-asserted-by":"crossref","first-page":"S1145","DOI":"10.1016\/j.ajog.2021.08.027","article-title":"Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction","volume":"226","author":"McLaughlin","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2026.07.026_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00125-008-1182-x","article-title":"Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women","volume":"52","author":"Yu","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajog.2026.07.026_bib37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/uog.14811","article-title":"Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history","volume":"45","author":"Tsiakkas","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc19-0967","article-title":"Urinary and serum angiogenic markers in women with preexisting diabetes during pregnancy and their role in preeclampsia prediction","volume":"43","author":"Zen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2026.07.026_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/10641955.2022.2068574","article-title":"Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus","volume":"41","author":"Kapustin","year":"2022","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2026.07.026_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/jdr\/3987453","article-title":"sFlt-1\/PlGF ratio in the prediction of preeclampsia in pregnant women with diabetic kidney disease","volume":"2025","author":"Kornacki","year":"2025","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajog.2026.07.026_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/10641955.2013.837175","article-title":"The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes","volume":"33","author":"Cohen","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2026.07.026_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.placenta.2024.12.025","article-title":"The relationship between abnormal fetoplacental Dopplers, angiogenic markers of placental dysfunction and adverse perinatal outcomes in diabetic pregnancies with small fetuses\u2014a prospective study","volume":"160","author":"Hong","year":"2025","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2026.07.026_bib43","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1753495X251327462","article-title":"Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy","volume":"18","author":"Gladstone","year":"2025","journal-title":"Obstet Med"},{"key":"10.1016\/j.ajog.2026.07.026_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajog.2019.07.032","article-title":"The physiology of intrapartum fetal compromise at term","volume":"222","author":"Turner","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ajog.2026.07.026_bib47","series-title":"Sixteenth annual report of the Perinatal and Maternal Mortality Review Committee: reporting mortality and morbidity 2021","year":"2023"},{"key":"10.1016\/j.ajog.2026.07.026_bib48","first-page":"99","article-title":"Pre-eclampsia in Aotearoa New Zealand: elevating clinical vigilance and equity-a viewpoint","volume":"138","author":"Gupta","year":"2025","journal-title":"N Z Med J"},{"key":"10.1016\/j.ajog.2026.07.026_bib49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/uog.23668","article-title":"ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis","volume":"58","author":"Shen","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2026.07.026_bib50","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.3390\/ijms27093752","volume":"27","author":"Petrica","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajog.2026.07.026_bib51","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826003935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937826003935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:08:57Z","timestamp":1788552537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937826003935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"alternative-id":["S0002937826003935"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2026.07.026","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal serum soluble fms-like tyrosine kinase 1 and placental growth factor as markers of occult placental dysfunction and fetal risk in pregestational diabetes: a prospective masked cohort study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2026.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}